Replies to post #25051 on BioCurex, Inc.(fka BOCX)

[odd Kelly]

nice to see some sanity on this board...bravo Turtle... maybe you could get a radiation oncologist to state an opinion.
I've been away for awhile, having become bored with the bantering of the regulars as there hasn't been much to discuss (except the IPO... on and on and ON).
Turtle may be right that this is the bottom but I wouldn't be to sure after following this stock for 8 or so years. It may go to 5 0r 6 cents after the hubbub dies down. IF some good news or a pump comes along (and I've been through them all) a savvy investor could make a few bucks buying and selling at the right times (potential earnings of 30% all the way up to ? [your guess is as good as mine]). I know I made and lost quite a bit over the years playing the peaks and valleys of this stock. It IS a lot of fun as long as you realize that despite the tech this stock may never go anywhere. It WILL however have more HIGHS and LOWS and as a penny stock there is money to be made.

[Gold Seeker]

TurtleBK stated: "I certainly disagree with that statement in principle, and am nearly shocked to hear it. However, the perspective of a radiation oncologist is bound to be different than an internist's, given that his interest is to perform radiation imaging to see cancer, and this product may lessen its necessity."

I agree with the above. IMO, a Radiologist would probably not want to mess with a test that did nothing but say you need to find the source. If it was a false positive, you could look forever. That is why he first stated, location, location, location. he would just using imaging from the git go and look for immediate results.

Anyway, he was the only independent doctor I have found making any comments about RECAF. Everyone on the board believes what Moro is saying who is highly biased. If RECAF was all that Moro stated, there is just no way Abbott would not have proceeded.

That is my biggest problem with this stock. Both Abbott and Inverness have changed their minds about using it on their mass analycers. Moro also cannot get any other labs interested in the manual ELISA tests. Moro will tell investors he is in discussions with multiple labs and then nothing happens. Right now, I just totally disregard anything Moro says.

Everyone touts the scientific board that Moro paid to get onboard back in 2002. None of those say anything or pay any attention. A years or so ago, one of the investors contacted Dr. Sell and asked about RECAF. He id not even know what Moro was doing.

Who do you believe. Moro was first stating in the S1 that Inverness would pay royalties this year. In the latest S1, that changed to say he did not know when nor how Inverness would pay any minimum royalties. That is a huge change so does Moro tell the truth?

[Gold Seeker]

TurtleBK stated: "As far as "personalization" of the product, I believe that to be fully within the realm of what can be done here. There wouldn't be much need to test with this product more than once a year in my opnion, so antibody half-life will not be an issue (if the product 'sticks' to the chemical complexes it identifies, then the next round would miss what has already been tagged, and this could skew the subsequent test). So sure, I think this could be something that could be a part of an annual physical for adults over 30. "

You are lacking some understanding of this test. It is not imaging where tagging is done. It is an immunoassy done on serum from a blood draw. You could test as often as someone was willing to draw blood.